FUJII Hironori 藤井宏典

… Alternative Names

Fujii Hironori 藤井宏典

Less

Researcher Number	90775173
Other IDs
Affiliation (Current)	2025: 岐阜大学, 医学部附属病院, 主任薬剤師 2025: 岐阜薬科大学, 薬学部, 客員共同研究員
Affiliation (based on the past Project Information) *help	2025: 岐阜大学, 医学部附属病院, 主任薬剤師 2020 – 2022: 岐阜薬科大学, 薬学部, 客員共同研究員
Review Section/Research Field	Principal Investigator Basic Section 47060:Clinical pharmacy-related
Keywords	Principal Investigator 予後マーカー / 好中球減少 / FOLFIRINOX療法 / 切除不能進行膵がん / 大腸がん / 治療効果 / 膵がん / MDSCs / 時間依存性Cox回帰分析 / 不死時間バイアス … More / フローサイトメトリー解析 / 生存期間 / がん化学療法 / MDSC / 重篤な好中球減少 Less

がん悪液質におけるグレリン抵抗性に関連したアナモレリンの治療効果不良因子の解明Principal Investigator
- Principal Investigator
  
  藤井宏典
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gifu University
Development of a novel prognostic marker for pancreatic cancer chemotherapy as an indicator of MDSC reduction due to myelosuppression.Principal Investigator
- Principal Investigator
  
  Fujii Hironori
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Gifu Pharmaceutical University

All 2022 2021 2020

All Journal Article

[Journal Article] Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer2022
- Author(s)
  Sadaka S, Iwashita T, Fujii H, Kato-Hayashi H, Ohata K, Uemura S, Shimizu M, Suzuki A
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 11 Issue: 19 Pages: 5895-5895
- DOI
  10.3390/jcm11195895
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07152, KAKENHI-PROJECT-20K16081
[Journal Article] Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.2022
- Author(s)
  Fujii H, Ueda Y, Hirose C, Ohata K, Sekiya K, Kitahora M, Sadaka S, Yamamoto S, Watanabe D, Kato-Hayashi H, Iihara H, Kobayashi R, Kaburaki M, Matsuhashi N, Takahashi T, Makiyama A, Yoshida K, Suzuki A.
- Journal Title
  
  Journal of Pharmaceutical Health Care and Sciences
  
  Volume: 8 Issue: 1 Pages: 8-8
- DOI
  10.1186/s40780-022-00239-w
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07152, KAKENHI-PROJECT-20K16081
[Journal Article] Proton pump inhibitors affect capecitabine efficacy in patients with stage II-III colorectal cancer: a multicenter retrospective study2022
- Author(s)
  Kitazume Y, Kawazoe H, Uozumi R, Yoshizawa T, Iihara H, Fujii H, Takahashi M, Arai T, Murachi Y, Sato Y, Mikami T, Hashiguchi K, Yamazaki T, Takahashi K, Fujita Y, Hosokawa Y, Morozumi I, Tsuchiya M, Yokoyama A, Hashimoto H, Yamaguchi M.
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1 Pages: 6561-6561
- DOI
  10.1038/s41598-022-10008-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16081
[Journal Article] Cancer cachexia as a determinant of efficacy of first?line pembrolizumab in patients with advanced non?small cell lung cancer2022
- Author(s)
  Fujii Hironori、Araki Ayumu、Iihara Hirotoshi、Kaito Daizo、Hirose Chiemi、Kinomura Motohiko、Yamazaki Mizuki、Endo Junki、Inui Toshiya、Yanase Komei、Sasaki Yuka、Gomyo Takenobu、Sakai Chizuru、Kawae Daisuke、Kitamura Yu、Fukui Masachika、Kobayashi Ryo、Ohno Yasushi、Suzuki Akio
- Journal Title
  
  Molecular and Clinical Oncology
  
  Volume: 16 Issue: 4 Pages: 91-91
- DOI
  10.3892/mco.2022.2524
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16081
[Journal Article] Association between the Co-administration of Histamine H2 Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis2022
- Author(s)
  Yamazaki T, Uozumi R, Kawazoe H, Kitazume Y, Iihara H, Fujii H, Takahashi M, Arai T, Murachi Y, Sato Y, Mikami T, Hashiguchi K, Yoshizawa T, Takahashi K, Fujita Y, Hosokawa Y, Morozumi I, Tsuchiya M, Yokoyama A, Hashimoto H, Furukawa T.
- Journal Title
  
  Journal of Cancer
  
  Volume: 13 Issue: 10 Pages: 3073-3083
- DOI
  10.7150/jca.73385
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16081
[Journal Article] Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer2022
- Author(s)
  Fujii H, Sadaka S, Ajisawa K, Okumura N, Makiyama A, Iihara H, Yasufuku I, Ohata K, Kobayashi R, Tanaka Y, Hayashi H, Suzuki A
- Journal Title
  
  Anticancer Resarch
  
  Volume: 42 Issue: 9 Pages: 4581-4588
- DOI
  10.21873/anticanres.15961
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07152, KAKENHI-PROJECT-20K10400, KAKENHI-PROJECT-20K16081
[Journal Article] One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis2022
- Author(s)
  Watanabe D, Iihara H, Fujii H, Makiyama A, Nishida S, Suzuki A.
- Journal Title
  
  Oncologist
  
  Volume: 27 Issue: 6 Pages: e524-e532
- DOI
  10.1093/oncolo/oyac060
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16081
[Journal Article] Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy: a retrospective observational study2021
- Author(s)
  Fujii H, Koda M, Sadaka S, Ohata K, Kato-Hayashi H, Iihara H, Kobayashi R, Ishihara T, Uemura S, Iwashita T, Hayashi H, Sugiyama T, Shimizu M, Suzuki A.
- Journal Title
  
  Journal of Pharmaceutical Health Care and Sciences
  
  Volume: 7 Issue: 1 Pages: 27-27
- DOI
  10.1186/s40780-021-00210-1
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07152, KAKENHI-PROJECT-20K10400, KAKENHI-PROJECT-20K16081
[Journal Article] Comparison of chemotherapy-induced nausea and vomiting between gemcitabine plus nab-paclitaxel combination chemotherapy and gemcitabine monotherapy in patients with advanced pancreatic cancer.2021
- Author(s)
  Ohata K, Fujii H, Sadaka S, Kato-Hayashi H, Iihara H, Kobayashi R, Uemura S, Iwashita T, Shimizu M, Suzuki A.
- Journal Title
  
  Anticancer Research
  
  Volume: 41 Issue: 7 Pages: 3643-3648
- DOI
  10.21873/anticanres.15154
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07152, KAKENHI-PROJECT-20K10400, KAKENHI-PROJECT-20K16081
[Journal Article] Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.2021
- Author(s)
  Daichi Watanabe, Hironori Fujii, Yunami Yamada, Nobuhisa Matsuhashi, Akitaka Makiyama, Hirotoshi Iihara, Takao Takahashi, Shigeru Kiyama, Ryo Kobayashi, Kazuhiro Yoshida, Akio Suzuki
- Journal Title
  
  International journal of clinical oncology
  
  Volume: 26 Issue: 7 Pages: 1257-1263
- DOI
  10.1007/s10147-021-01910-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K10400, KAKENHI-PROJECT-20K16081
[Journal Article] Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept2021
- Author(s)
  YAMADA YUNAMI、MATSUHASHI NOBUHISA、FUJII HIRONORI、MAKIYAMA AKITAKA、IIHARA HIROTOSHI、TAKAHASHI TAKAO、WATANABE DAICHI、KIYAMA SHIGERU、KOBAYASHI RYO、SUZUKI AKIO、YOSHIDA KAZUHIRO
- Journal Title
  
  Anticancer Research
  
  Volume: 41 Issue: 1 Pages: 533-541
- DOI
  10.21873/anticanres.14805
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16081
[Journal Article] Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy2021
- Author(s)
  SATO YUKINA、IIHARA HIROTOSHI、KINOMURA MOTOHIKO、HIROSE CHIEMI、FUJII HIRONORI、ENDO JUNKI、YANASE KOMEI、KAITO DAIZO、SASAKI YUKA、GOMYO TAKENOBU、SAKAI CHIZURU、IWAI MASAMICHI、TSUBOI YOSHIKI、ISHIHARA TAKUMA、KOBAYASHI RYO、OHNO YASUSHI、SUZUKI AKIO
- Journal Title
  
  Anticancer Research
  
  Volume: 41 Issue: 3 Pages: 1615-1620
- DOI
  10.21873/anticanres.14923
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16081, KAKENHI-PROJECT-20K10400
[Journal Article] Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer2020
- Author(s)
  WATANABE DAICHI、FUJII HIRONORI、MATSUHASHI NOBUHISA、IIHARA HIROTOSHI、YAMADA YUNAMI、ISHIHARA TAKUMA、TAKAHASHI TAKAO、YOSHIDA KAZUHIRO、SUZUKI AKIO
- Journal Title
  
  Anticancer Research
  
  Volume: 40 Issue: 4 Pages: 2379-2386
- DOI
  10.21873/anticanres.14207
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K16081

1. HAYASHI Hideki

# of Collaborated Projects: 0 results

# of Collaborated Products: 5 results
2. KOBAYASHI Ryo

# of Collaborated Projects: 0 results

# of Collaborated Products: 5 results
3. 鈴木昭夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 6 results
4. 渡邉崇量

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

FUJII Hironori 藤井 宏典

Fujii Hironori 藤井 宏典

Research Projects

Research Products

Co-Researchers

がん悪液質におけるグレリン抵抗性に関連したアナモレリンの治療効果不良因子の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a novel prognostic marker for pancreatic cancer chemotherapy as an indicator of MDSC reduction due to myelosuppression.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Impact of First-Line FOLFIRINOX-Induced Peripheral Neuropathy on the Efficacy of Second-Line GnP in Patients with Unresectable Advanced Pancreatic Cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Proton pump inhibitors affect capecitabine efficacy in patients with stage II-III colorectal cancer: a multicenter retrospective study2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cancer cachexia as a determinant of efficacy of first?line pembrolizumab in patients with advanced non?small cell lung cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association between the Co-administration of Histamine H2 Receptor Antagonists and the Effectiveness of Capecitabine in Patients with Colorectal Cancer: Propensity Score Analysis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced Gastric Cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy: a retrospective observational study2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparison of chemotherapy-induced nausea and vomiting between gemcitabine plus nab-paclitaxel combination chemotherapy and gemcitabine monotherapy in patients with advanced pancreatic cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dose Adjustment of Oxaliplatin Based on Renal Function in Patients With Metastatic Colorectal Cancer2020

Author(s)

Journal Title

FUJII Hironori 藤井宏典

Fujii Hironori 藤井宏典